جزییات کتاب
Reviews focused topics – both clinical and basic science - in the fast-moving area of IBD, providing emphasis on the current challenges faced in the successful management of the diseaseTurn to Challenges in Inflammatory Bowel Disease (IBD) when you need an expert opinion on the new, unusual or controversial areas of IBD and not just the tried and tested information. Current and concise reviews of the latest scientific discoveries are translated into cutting-edge clinical guidance to address those challenging cases faced by every medical team caring for patients with IBD. Refer to this book to answer burning questions, to read an in depth review of the controversial topics and to provide a clear explanation of issues.Content: Chapter 1 Global Changes in Incidence (pages 1–13): Richard F. A. Logan and Emma L. ArmitageChapter 2 The Role of Genetics in Inflammatory Bowel Disease (pages 14–32): John B. Beckly, Tariq Ahmad and Derek P. JewellChapter 3 Microbial Sensing in the Intestine by Pattern Recognition Receptors (pages 33–43): Robin G. Lorenz and Charles O. ElsonChapter 4 The Role of Bacteria (pages 44–56): Robert Penner and Karen MadsenChapter 5 The Appendix ? How Might it Influence Susceptibility to Ulcerative Colitis: The Legend of Qebehsenuef (pages 57–63): Kenneth CroitoruChapter 6 What are the Controversies in Histopathological Diagnosis? (pages 65–84): Bryan F. Warren and Neil A. ShepherdChapter 7 The Challenges of using Capsule Endoscopy in the Diagnosis and Management of Inflammatory Bowel Disease (pages 85–104): Gary C. Chen and Simon K. LoChapter 8 Cross?Sectional Imaging of Inflammatory Bowel Disease (pages 105–116): Stuart Taylor and Steve HalliganChapter 9 Mesalazine for Maintenance Therapy in Ulcerative Colitis ? How much, How long? (pages 117–123): Miles P. Sparrow, Wee?Chian Lim and Stephen B. HanauerChapter 10 Refractory Distal Colitis (pages 124–143): Simon TravisChapter 11 Pharmabiotics and Inflammatory Bowel Disease ? On the Verge of Evidence?based Medicine (pages 144–153): Fergus Shanahan, Jude Ryan and Shomik SibartieChapter 12 Current Controversies in the Surgical Management of Ulcerative Colitis (pages 154–166): R. John Nicholls and Mark J. CheethamChapter 13 What are the Causes and Treatment of Ileoanal Pouch Dysfunction? (pages 167–178): Alan F. Horgan, William J. Sandborn and John H. PembertonChapter 14 Is Mesalazine Useful in Crohn's Disease? (pages 179–193): A. Hillary SteinhartChapter 15 Steroids or Nutrition? (pages 194–205): Miquel A. GassullChapter 16 Do Antibiotics have a Role in Crohn's Disease? (pages 206–212): Severine Vermeire and Paul RutgeertsChapter 17 The Optimal use of Infliximab in Crohn's Disease (pages 213–220): Geert D'HaensChapter 18 Designer Drugs: From Bench to Bedside (pages 221–231): Stephan R. Targan and Loren C. KarpChapter 19 Current Controversies in the Surgical Management of Crohn's Disease (pages 232–245): W. M. Chambers, I. Lindsey and N. J. MortensenChapter 20 Perianal Crohn's Disease (pages 246–265): Carl J. Brown and Robin S. McLeodChapter 21 What is Dysplasia? (pages 266–280): Karel GeboesChapter 22 Colonoscopic Surveillance — If and When? (pages 281–292): Urban Sjoqvist and Robert LofbergChapter 23 Cancer: New Colonoscopic Techniques (pages 293–302): Ralf Kiesslich and Markus F. NeurathChapter 24 Molecular Markers ? A Realistic Hope? (pages 303–311): Jacintha N. O'Sullivan and Teresa A. BrentnallChapter 25 Adenomas versus Dysplasia Associated Lesion or Mass ? Recognition and Management? (pages 312–326): Maha Guindi and Robert H. RiddellChapter 26 Growth Impairment in Children (pages 327–339): Thomas D. Walters and Anne M. GriffithsChapter 27 Osteopenia (pages 340–359): Subrata GhoshChapter 28 Pregnancy (pages 360–368): Philippe MarteauChapter 29 Can Prognosis of Ulcerative Colitis be Predicted? (pages 369–376): Robert Hilsden and Lloyd Sutherland